MX2021007311A - Metodos y composiciones para reducir la amplificacion no especifica en reacciones de amplificacion isotermica. - Google Patents

Metodos y composiciones para reducir la amplificacion no especifica en reacciones de amplificacion isotermica.

Info

Publication number
MX2021007311A
MX2021007311A MX2021007311A MX2021007311A MX2021007311A MX 2021007311 A MX2021007311 A MX 2021007311A MX 2021007311 A MX2021007311 A MX 2021007311A MX 2021007311 A MX2021007311 A MX 2021007311A MX 2021007311 A MX2021007311 A MX 2021007311A
Authority
MX
Mexico
Prior art keywords
amplification
compositions
methods
reactions
reduce nonspecific
Prior art date
Application number
MX2021007311A
Other languages
English (en)
Spanish (es)
Inventor
Joseph Carl Gaiteri
Rixun Fang
Brenna Hearn Lord
Yuh- Min CHIANG
Ronald Phillip Chiarello
Original Assignee
Alveo Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alveo Tech Inc filed Critical Alveo Tech Inc
Publication of MX2021007311A publication Critical patent/MX2021007311A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
MX2021007311A 2018-12-20 2019-12-18 Metodos y composiciones para reducir la amplificacion no especifica en reacciones de amplificacion isotermica. MX2021007311A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862782610P 2018-12-20 2018-12-20
PCT/US2019/067134 WO2020132042A1 (en) 2018-12-20 2019-12-18 Methods and compositions to reduce nonspecific amplification in isothermal amplification reactions

Publications (1)

Publication Number Publication Date
MX2021007311A true MX2021007311A (es) 2021-09-21

Family

ID=71101681

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021007311A MX2021007311A (es) 2018-12-20 2019-12-18 Metodos y composiciones para reducir la amplificacion no especifica en reacciones de amplificacion isotermica.

Country Status (8)

Country Link
US (1) US20220056511A1 (cg-RX-API-DMAC7.html)
EP (1) EP3899023A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022515192A (cg-RX-API-DMAC7.html)
CN (1) CN113454236A (cg-RX-API-DMAC7.html)
AU (1) AU2019403220A1 (cg-RX-API-DMAC7.html)
CA (1) CA3123839A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021007311A (cg-RX-API-DMAC7.html)
WO (1) WO2020132042A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10196678B2 (en) 2014-10-06 2019-02-05 ALVEO Technologies Inc. System and method for detection of nucleic acids
AU2017330304A1 (en) 2016-09-23 2019-04-11 Alveo Technologies, Inc. Methods and compositions for detecting analytes
AU2019401601B2 (en) 2018-12-20 2026-04-02 Alveo Technologies, Inc. Handheld impedance-based diagnostic test system for detecting analytes
US20220042117A1 (en) * 2020-08-06 2022-02-10 Roche Molecular Systems, Inc. COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
US12472492B2 (en) 2020-08-14 2025-11-18 Alveo Technologies, Inc. Systems and methods of sample depositing and testing
JP2025531820A (ja) * 2022-09-07 2025-09-25 ベクトン・ディキンソン・アンド・カンパニー 検出特異性改善のための修飾分子ビーコン
PL442248A1 (pl) * 2022-09-12 2024-03-18 Genomtec Spółka Akcyjna Zestaw starterów, skład mieszaniny reakcyjnej oraz metoda wykrywania ludzkiego syncytialnego wirusa oddechowego (ang. Human Respiratory Syncital Virus) typ A i typ B (RSVA) i (RSVB)
WO2024191684A1 (en) * 2023-03-10 2024-09-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Detection of hepatitis c virus ribonucleic acid from whole blood using reverse transcription loop-mediated isothermal amplification
WO2026006021A2 (en) 2024-06-25 2026-01-02 Alveo Technologies, Inc. Systems and methods of sample depositing and testing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ554701A (en) * 2004-10-18 2010-03-26 Univ Brandeis Reagents and methods for improving reproducibility and reducing mispriming in PCR amplification
EP1943348B1 (en) * 2005-10-03 2013-01-02 Life Technologies Corporation Compositions, methods, and kits for amplifying nucleic acids
US8097414B2 (en) * 2005-11-25 2012-01-17 K. K. Dnaform Method for detecting and amplifying nucleic acid
JP5025489B2 (ja) * 2005-12-28 2012-09-12 学校法人麻布獣医学園 標的配列の特異的高感度増幅法
US9169514B2 (en) * 2010-12-03 2015-10-27 Brandeis University Detecting nucleic acid variations within populations of genomes
WO2012121225A1 (ja) * 2011-03-04 2012-09-13 株式会社カネカ 核酸の検出方法及びその方法に用いるデバイス、キット
EP3058100A4 (en) * 2013-10-18 2017-04-19 California Institute of Technology Enhanced nucleic acid identification and detection
US10240178B2 (en) * 2014-12-19 2019-03-26 Brandeis University Mispriming prevention reagents

Also Published As

Publication number Publication date
AU2019403220A1 (en) 2021-07-15
CN113454236A (zh) 2021-09-28
JP2022515192A (ja) 2022-02-17
US20220056511A1 (en) 2022-02-24
EP3899023A4 (en) 2022-10-12
EP3899023A1 (en) 2021-10-27
CA3123839A1 (en) 2020-06-25
WO2020132042A1 (en) 2020-06-25

Similar Documents

Publication Publication Date Title
PH12019502171A1 (en) Composition and methods for immunooncology
EP4219559A3 (en) Antibodies for lilrb2
PH12018501159A1 (en) Composition and methods for immunooncology
EP4582556A3 (en) Methods and compositions for whole transcriptome amplification
PE20191812A1 (es) Compuestos y metodos para la reduccion celular especifica de tumor
WO2019183359A8 (en) Methods and compositions for molecular authentication
EP4545544A3 (en) Modified crispr rna and modified single crispr rna and uses thereof
MX2015011944A (es) Evaluacion cuantitativa para la eficacia de los casquetes de arn mensajero.
EA201991662A1 (ru) Новые системы и способы ферментации
WO2018175258A8 (en) Methods and compositions for preparing nucleic acid libraries
EP4425179A3 (en) Compositions and methods for enhanced fluorescence
MX2020000957A (es) Anticuerpos anti-sirp-alfa y metodos relacionados.
MX379161B (es) Composiciones ricas en nutrientes.
GT201600171A (es) Anticuerpos anti-cd38 para el tratamiento de la leucemia linfoblástica aguda
WO2018146557A3 (en) Long double-stranded rna for rna interference
EP4700161A3 (en) Direct-to-library methods, systems, and compositions
AR111835A1 (es) Composiciones estables de inoculantes que comprenden aceites vegetales metilados
MX380744B (es) Métodos y dispositivos para transmitir información de sistema bajo demanda.
BR112021006517A2 (pt) composição catalisadora de três vias, artigo catalisador para tratamento de gás de escape, e, método para tratamento de um gás de escape
EP4628631A3 (en) Conditional primer extension for single-molecule detection
CA3010678A1 (en) Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapy
MX393266B (es) Composiciónpara usarse en terapia de microbiota
PH12016500620A1 (en) Intrauterine delivery system
MX2017011198A (es) Biomarcadores para preeclampsia.
WO2020026031A3 (en) Methods and systems for target enrichment